furoxan

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
A novel series of furoxan (1,2,5-oxadiazole 2-oxide) (compounds 3, 4a and -b, 13a and -b, and 14a to -f) and benzofuroxan (benzo… (More)
Is this relevant?
2011
2011
A series of furoxan-based nitric oxide-releasing chrysin derivatives were synthesized. Pharmacological assays indicated that all… (More)
Is this relevant?
2009
2009
The parent furoxan (1,2,5-oxadiazole 2-oxide), synthesized from glyoxime and NO(2)(g), has been investigated in the gas phase for… (More)
Is this relevant?
2007
2007
The structure of fenoterol, a beta2-adrenoceptor agonist used in therapy, has been joined with furoxan NO-donor moieties to give… (More)
Is this relevant?
2006
2006
Incorporation of a nitric oxide (NO)-releasing moiety in aspirin can overcome its gastric side effects. We investigated the NO… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2006
2006
Furoxan derivatives with in vitro cytotoxic activity were investigated as antitumoral agents in vivo. The compounds were tested… (More)
Is this relevant?
2005
2005
Furoxan derivatives bearing a sulfone moiety at position 3 or 4 were synthesized and tested for their antimalarial action on the… (More)
Is this relevant?
2004
2004
The article focuses attention on furoxan derivatives (1,2,5-oxadiazole 2-oxides) as NO donors. Possible mechanisms for NO release… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 5
  • figure 6
Is this relevant?
1997
1997
The synthesis, characterization, NO donor properties, and in vitro vasodilating activity of a series of water soluble furoxans (5… (More)
Is this relevant?
1995
1995
1. The mechanism of action and biological activity of a series of R-substituted and di-R-substituted phenylfuroxans is reported… (More)
Is this relevant?